Tackling cancer: the NHS’ Long Term Plan
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is taking on cancer in line with the Long Term Plan
PharmaTimes Magazine Archive
Magazine highlights
View more from the latest edition
Side by side
David Evendon-Challis and Dr John Creek on why collaboration will be key in developing credible microbiome solutions
In the shadows
The pharma industry may just have more unsung heroes than any other.
Leading the pack
Tom Cowap offers four reasons to get excited about the UK’s privately owned pharma businesses
Marching on
High levels of pharma M&A activity will almost certainly continue, driven by a number of long-term trends, predicts James Baillieu
Transforming the landscape
How big tech and big pharma partnerships are providing deeper insights and improving patient outcomes
Be your best
Delivering a step-change in self-care
The modern supply chain
Roddy Martin discusses the journey to creating an end-to-end business network that enables patient-driven orchestration
